Drug Profile
Pinocembrin
Alternative Names: 5,7-Dihydroxyflavanone; DL-0108Latest Information Update: 24 Aug 2017
Price :
$50
*
At a glance
- Originator CSPC ZhongQi Pharmaceutical Technology
- Class Anti-ischaemics; Flavanones; Flavonoids; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Stroke
Most Recent Events
- 24 Aug 2017 No development reported - Phase-II for Stroke in China (IV)
- 16 Jun 2016 CSPC suspends a phase II trial in Stroke in China (NCT02059785)
- 01 Jun 2013 Phase-II clinical trials in Stroke in China (IV)